[1]阿依姑再丽·阿地力,陈麒.止喘颗粒联合喘可治穴位注射治疗慢性阻塞性肺疾病急性加重期疗效观察[J].西部中医药,2024,37(10):133-136.[doi:10.12174/j.issn.2096-9600.2024.10.30]
　Ayiguzaili·ADILI,CHEN Qi.Clinical Observation on Treating AECOPD with Asthma-relieving Granules and Acupoint Injection of Chuankezhi[J].Western Journal of Traditional Chinese Medicine,2024,37(10):133-136.[doi:10.12174/j.issn.2096-9600.2024.10.30]
点击复制

止喘颗粒联合喘可治穴位注射治疗慢性阻塞性肺疾病急性加重期疗效观察
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
37
期数:
2024年10期
页码:
133-136
栏目:
特色医疗
出版日期:
2024-10-15

文章信息/Info

Title:
Clinical Observation on Treating AECOPD with Asthma-relieving Granules and Acupoint Injection of Chuankezhi
作者:
阿依姑再丽·阿地力, 陈麒
喀什地区第二人民医院，新疆 喀什 844000
Author(s):
Ayiguzaili·ADILI , CHEN Qi
Kashgar Prefecture Second People's Hospital, Kashgar 844000, China
关键词:
慢性阻塞性肺疾病; 穴位注射; 气道黏液高分泌; 炎性因子; 止喘颗粒; 喘可治
Keywords:
chronic obstructive pulmonary disease; acupoint injection; airway mucus hypersecretion; inflammatory factors; asthma-relieving granules
分类号:
R256.12
DOI:
10.12174/j.issn.2096-9600.2024.10.30
文献标志码:
B
摘要:
目的观察止喘颗粒联合喘可治穴位注射治疗慢性阻塞性肺疾病急性加重期（acute exacerbation of chronic obstructive pulmonary disease，AECOPD）的临床疗效。 方法将120例AECOPD患者按随机数字表法分为对照组和观察组各60例。对照组予常规西医干预措施，观察组在此基础上予止喘颗粒联合喘可治穴位注射；连续治疗10天后比较两组患者治疗前后中医证候积分，肺功能指标［第一秒用力呼气量（forced expiratory volume in one second，FEV1），第一秒用力肺活量/潮气量比值（first second forced vital capacity/tidal volume，FEV1/FVC）］，气道黏液分泌指标［中性粒细胞弹力蛋白酶（neutrophil elastase，NE）、杯状细胞分泌黏液蛋白（mucin 5 subtype AC，MUC5AC）］及炎性因子［白细胞介素4（interleukin-4，IL-4）、IL-17、干扰素γ（interferon-γ，IFN-γ）］水平与临床疗效。 结果观察组总有效率为93.3%（56/60），高于对照组的80.0%（48/60）（P＜0.05）；观察组患者中医证候积分低于对照组（P＜0.05）；FEV1、FEV1/FVC水平高于对照组（P＜0.05）；两组患者NE、MUC5AC水平均降低（P＜0.05），观察组低于对照组（P＜0.05）；观察组IL-4、IL-17水平低于对照组，IFN-γ水平高于对照组（P＜0.05）。 结论止喘颗粒联合喘可治穴位注射能够改善AECOPD患者临床症状和肺功能，减轻气道黏液高分泌状态，抑制炎性反应，效果优于常规西医干预措施。
Abstract:
ObjectiveTo observe therapeutic effects of asthma-relieving granules combined with acupoint injection of Chuankezhi (Asthma-healing Injection) in the treatment of acute exacerbation of chronic obstructive pulmonary disease (AECOPD). MethodsA total of 120 AECOPD patients were divided into the control group and the observation group according to random number table method with 60 cases in each group. Conventional intervention measures of Western medicine was administered to the control group, while the observation group was given asthma-relieving granules and acupoint injection of Chuankezhi based on the treatment of the control group. To compare TCM syndrome integrals, the indexes of lung function including FEV1, FEV1/FVC, airway mucus secretion indexes such as NE and MUC5AC and the levels of inflammatory factors including IL-4, IL-17 and IFN-γ, as well as clinical effecs before and after the treatment after ten days of treatment. ResultsTotal effective rate of the observation group was 93.3% (56/60), higher than 80.0% (48/60) of the control group (P<0.05); TCM syndrome integrals of the observation group were lower than these of the control group (P<0.05), the levels of FEV1 and FEV1/FVC higher than these of the control group (P<0.05); the levels of NE and MUC5AC were decreased in the two groups (P<0.05), the observation group was lower than the control group (P<0.05); the observa-tion group was lower than the control group in the expressions of IL-4 and IL-17, higher than the control group in the levels of IFN-γ(P<0.05). ConclusionAsthma-relieving granules combined with acupoint injection of Chuankezhi could improve AECOPD patients' clinical symptoms and lung function, alleviate airway mucus hypersecretion, inhibit inflammatory reaction, and its effects superior to conventional intervention measures of Western medicine.

相似文献/References:

[1]马腾.透穴疗法联合神经生长因子穴位注射治疗小儿麻痹性斜视50例临床观察[J].西部中医药,2012,25(12):92.
　MA Teng.Clinical Observation on Point-to-point Therapy and Point Injection of Nerve Growth Factor for 50 Cases of Infant Paralytic Strabismus[J].Western Journal of Traditional Chinese Medicine,2012,25(10):92.
[2]郑引水,马国义.曲安奈德注射液穴位注射治疗慢性阻塞性肺病急性加重期 35 例[J].西部中医药,2014,27(08):115.
[3]王萍.慢性阻塞性肺病患者实施临床护理路径的疗效分析[J].西部中医药,2014,27(11):140.
[4]何国华,赵志亮.肾周阿是穴注射生理盐水治疗肾绞痛28例*[J].西部中医药,2015,28(02):111.
[5]王 燕,孙凤英,倪 军.慢性阻塞性肺疾病患者非药物治疗依从性与生活质量相关性的研究[J].西部中医药,2015,28(03):89.
[6]郭晓燕,尹广超,陆城华,等.川芎平喘合剂对COPD患者血管内皮功能的调节作用[J].西部中医药,2015,28(05):1.
[7]王振伟,杨佩兰,沈丽,等.百部养肺煎膏治疗COPD稳定期患者的临床研究[J].西部中医药,2015,28(05):56.
[8]章淑萍,杨姒姚,邓志文,等.香丹穴位注射对慢性乙型肝炎疗效的影响[J].西部中医药,2015,28(11):115.
[9]赵宇冰,林丽明.老年慢性阻塞性肺疾病患者缓解期的社区康复治疗[J].西部中医药,2012,25(08):59.
　ZHAO Yu-bing,LIN Li-ming.Community Rehabilitation Therapy for Senile Patients with COPD at Remission Stage[J].Western Journal of Traditional Chinese Medicine,2012,25(10):59.
[10]张莉,韩力辉,王淑珍.皮部放血结合穴位注射治疗软组织损伤及骨关节病所致疼痛152例[J].西部中医药,2013,26(06):103.
　ZHANG Li,HAN Lihui,WANG Shuzhen.Skin Blooding-letting Combined with Point Injection for 152 Cases of Pain Induced by Soft Tissue Injury and Osteoarthrosis[J].Western Journal of Traditional Chinese Medicine,2013,26(10):103.

备注/Memo

备注/Memo:
阿依姑再丽·阿地力（1984—），女，主治医师。研究方向：中医防治慢性呼吸系统疾病的临床研究。E-mail：aminaquhai@163.com。新疆维吾尔自治区自然科学基金面上项目（2020D01C084）；喀什地区应用技术研究与开发计划项目（KS2020014）。
更新日期/Last Update: 2024-10-15